Potentiation of nitric oxide-induced apoptosis in p53-/- vascular smooth muscle cells.

The functional role of p53 in nitric oxide (NO)-mediated vascular smooth muscle cell (VSMC) apoptosis remains unknown. In this study, VSMC from p53-/- and p53+/+ murine aortas were exposed to exogenous or endogenous sources of NO. Unexpectedly, p53-/- VSMC were much more sensitive to the proapoptotic effects of NO than were p53+/+ VSMC. Furthermore, this paradox appeared to be specific to NO, because other proapoptotic agents did not demonstrate this differential effect on p53-/- cells. NO-induced apoptosis in p53-/- VSMC occurred independently of cGMP generation. However, mitogen-activated protein kinase (MAPK) pathways appeared to play a significant role. Treatment of the p53-/- VSMC with S-nitroso-N-acetylpenicillamine resulted in a marked activation of p38 MAPK and, to a lesser extent, of c-Jun NH(2)-terminal kinase, mitogen-activated protein kinase kinase (MEK) 1/2, and p42/44 (extracellular signal-regulated kinase, ERK). Furthermore, basal activity of the MEK-p42/44 (ERK) pathway was increased in the p53+/+ VSMC. Inhibition of p38 MAPK with SB-203580 or of MEK1/2 with PD-98059 blocked NO-induced apoptosis. Therefore, p53 may protect VSMC against NO-mediated apoptosis, in part, through differential regulation of MAPK pathways.

[1]  H. Y. Li,et al.  Nitric oxide induces extensive apoptosis in endometrial epithelial cells in the presence of progesterone: involvement of mitogen-activated protein kinase pathways. , 2001, Molecular human reproduction.

[2]  L. Schall,et al.  Nitric oxide induces murine thymocyte apoptosis by oxidative injury and a p53‐dependent mechanism , 2001, Journal of leukocyte biology.

[3]  V. Schirrmacher,et al.  Nitric oxide-induced apoptosis in tumor cells. , 2001, Advances in cancer research.

[4]  Simon C Watkins,et al.  Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. , 2000, Journal of vascular surgery.

[5]  M. Yaffe,et al.  MAP kinase pathways activated by stress: the p38 MAPK pathway. , 2000, Critical care medicine.

[6]  A. Herman,et al.  Apoptosis in atherosclerosis: beneficial or detrimental? , 2000, Cardiovascular research.

[7]  P. May,et al.  Twenty years of p53 research: structural and functional aspects of the p53 protein , 1999, Oncogene.

[8]  D. Sawyer,et al.  Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. , 1999, Circulation research.

[9]  M. Kibbe,et al.  Inducible nitric oxide synthase and vascular injury. , 1999, Cardiovascular research.

[10]  X. F. Wang,et al.  UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner. , 1999, Experimental cell research.

[11]  J. Fabiani,et al.  Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. , 1999, Atherosclerosis.

[12]  M. Kibbe,et al.  Nitric oxide synthase gene transfer to the vessel wall. , 1999, Current opinion in nephrology and hypertension.

[13]  MasatoraIwashina,et al.  Transfection of Inducible Nitric Oxide Synthase Gene Causes Apoptosis in Vascular Smooth Muscle Cells , 1998 .

[14]  M. Pincus,et al.  MEKK1/JNK signaling stabilizes and activates p53. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Simon C Watkins,et al.  Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. , 1998, Journal of the American College of Surgeons.

[16]  Michael Weller,et al.  Predicting response to cancer chemotherapy: the role of p53 , 1998, Cell and Tissue Research.

[17]  A. Zalewski,et al.  Early injury to the media after saphenous vein grafting. , 1998, Annals of Thoracic Surgery.

[18]  T. Littlewood,et al.  Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. , 1997, Circulation research.

[19]  A. Edwards,et al.  Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation. , 1997, Journal of cell science.

[20]  H. Lander,et al.  Differential Activation of Mitogen-activated Protein Kinases by Nitric Oxide-related Species* , 1996, The Journal of Biological Chemistry.

[21]  M. Yacoub,et al.  Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[22]  E. Nishio,et al.  Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. , 1996, Biochemical and biophysical research communications.

[23]  C. Harris,et al.  Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Ogihara,et al.  Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. , 1996, Hypertension.

[25]  G. Demers,et al.  Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis , 1996, Nature Medicine.

[26]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[27]  G. Evan,et al.  Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. , 1995, Circulation research.

[28]  S H Snyder,et al.  Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Bert Vogelstein,et al.  p53 function and dysfunction , 1992, Cell.